Drug Type Small molecule drug |
Synonyms Compound B9 |
Target |
Action inhibitors |
Mechanism CYP51A1 inhibitors(Cytochrome P450 51 inhibitors), PDL1 inhibitors(Programmed death-ligand 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC12H11BrN2O |
InChIKeyCDYNCVBGLQHJIS-UHFFFAOYSA-N |
CAS Registry2971825-58-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Mycoses | Discovery | China | 18 Jun 2024 |





